Sinopharm Group Records Lower Attributable Profit for Nine Months to September

MT Newswires Live10-28

Sinopharm Group (HKG:1099) recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-ago period, a Monday filing with the Hong Kong Exchange said.

The earnings per share stood at 1.69 yuan for the period, lower than 1.96 yuan per share recorded for the period last year.

The pharmaceutical company's total operating revenue for the nine months came in at 442.4 billion yuan, lower than 445.9 billion yuan from a year ago.

The company's shares were up over 1% in recent trade.

Price (HKD): $20.25, Change: $+0.27, Percent Change: +1.35%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2478121704?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 15:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478121704","market":"sh","top_or_hot":-1,"title":"Sinopharm Group Records Lower Attributable Profit for Nine Months to September","media":"MT Newswires Live","content":"<html><body><p> Sinopharm Group (HKG:1099) recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-ago period, a Monday filing with the Hong Kong Exchange said.</p><p>The earnings per share stood at 1.69 yuan for the period, lower than 1.96 yuan per share recorded for the period last year.</p><p>The pharmaceutical company's total operating revenue for the nine months came in at 442.4 billion yuan, lower than 445.9 billion yuan from a year ago.</p><p>The company's shares were up over 1% in recent trade.</p><p>Price (HKD): $20.25, Change: $+0.27, Percent Change: +1.35%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Group Records Lower Attributable Profit for Nine Months to September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Group Records Lower Attributable Profit for Nine Months to September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-28 15:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sinopharm Group (HKG:1099) recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4526","symbol_name":"热门中概股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478121704","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478121704","pubTimestamp":1730099981,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sinopharm Group  recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-ago period, a Monday filing with the Hong Kong Exchange said.The earnings per share stood at 1.69 yuan for the period, lower than 1.96 yuan per share recorded for the period last year.The pharmaceutical company's total operating revenue for the nine months came in at 442.4 billion yuan, lower than 445.9 billion yuan from a year ago.The company's shares were up over 1% in recent trade.Price : $20.25, Change: $+0.27, Percent Change: +1.35%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4526":"热门中概股","BK4588":"碎股","BK4023":"应用软件","BK1197":"保健护理产品经销商","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","HKD":"尚乘数科","01099":"国药控股","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1515":"抗疫概念","BK1500":"做空集合股","BK4585":"ETF&股票定投概念"},"translate_title":"国药集团截至9月的九个月归属利润下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1,"HKD":1},"content_text":"Sinopharm Group (HKG:1099) recorded net profit attributable to equity holders of the parent of 5.28 billion yuan for the nine months ended Sept. 30, lower than 6.10 billion yuan logged for the year-ago period, a Monday filing with the Hong Kong Exchange said.The earnings per share stood at 1.69 yuan for the period, lower than 1.96 yuan per share recorded for the period last year.The pharmaceutical company's total operating revenue for the nine months came in at 442.4 billion yuan, lower than 445.9 billion yuan from a year ago.The company's shares were up over 1% in recent trade.Price (HKD): $20.25, Change: $+0.27, Percent Change: +1.35%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478121704"}